1-7 of 7
Xavier Leleu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Poor Outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study

Open Access
Sarah Cayla, Lionel Karlin, Jerome Lambert, Anne Lazareth, Alexis Talbot, Mohamad Mohty, Florent Malard, Marie-Odile Petillon, Salomon Manier, Ibrahim Yakoub-Agha, Denis Caillot, Ingrid Lafon, Xavier Leleu, Niels Moya, Bruno Royer, Jean Marc Schiano de Colella, Gabriel Brisou, Cyrille Touzeau, Aurore Perrot, Pierre Bories, Laure Vincent, Hanane Guedon, Olivier Decaux, Benoît Ferment, Roch Houot, Steven Le Gouill, Noemie Bigot, Thierry Facon, Jill Corre, Hervé Avet-Loiseau, Philippe Moreau, Bertrand Arnulf
Journal: Blood Advances
Blood Adv bloodadvances.2025017597.
https://doi.org/10.1182/bloodadvances.2025017597
Published: 2025
Includes: Supplemental data
Journal Articles

Risk of synchronous and second primary malignancies in multiple myeloma transplant-ineligible treated with lenalidomide

Open Access
Thomas Systchenko, Ialy Nsiala, Arthur Bobin, Hélène Gardeney, Carine Motard, Gaelle Olivier, Florence Borde, Anne Corby, Christophe Roul, Emmanuel Fleck, Guillaume Denis, Céline Dieval, Philippe Mottaz, Annick Boscagli, Gautier Defossez, Xavier Leleu
Journal: Blood Advances
Blood Adv bloodadvances.2025016625.
https://doi.org/10.1182/bloodadvances.2025016625
Published: 2025
Includes: Supplemental data
Journal Articles

A.R.R.O.W.2: once- vs twice-weekly carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma

Free
Clinical Trials & Observations
Meletios A. Dimopoulos, Daniel Coriu, Sosana Delimpasi, Ivan Špička, Terry Upchurch, Belle Fang, Rakhshandra Talpur, Edward Faber, Meral Beksac, Xavier Leleu
Journal: Blood Advances
Blood Adv (2024) 8 (19): 5012–5021.
https://doi.org/10.1182/bloodadvances.2024013101
Published: 2024
Includes: Supplemental data
Journal Articles

Hodgkin lymphoma and female fertility: a multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazine

Free
Clinical Trials & Observations
Antoine Machet, Caroline Poudou, Cécile Tomowiak, Thomas Gastinne, Martine Gardembas, Thomas Systchenko, Niels Moya, Celine Debiais, Anthony Levy, Cécile Gruchet, Florence Sabirou, Stéphanie Noel, Sabrina Bouyer, Xavier Leleu, Vincent Delwail, Stéphanie Guidez
Journal: Blood Advances
Blood Adv (2023) 7 (15): 3978–3983.
https://doi.org/10.1182/bloodadvances.2021005557
Published: 2023
Journal Articles

Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study

Free
Clinical Trials & Observations
Saad Z. Usmani, Hang Quach, Maria-Victoria Mateos, Ola Landgren, Xavier Leleu, David Siegel, Katja Weisel, Xiaomei Shu, Chuang Li, Meletios Dimopoulos
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3739–3748.
https://doi.org/10.1182/bloodadvances.2023010026
Published: 2023
Includes: Supplemental data
Journal Articles

Denosumab compared with zoledronic acid on PFS in multiple myeloma: exploratory results of an international phase 3 study

Free
Clinical Trials & Observations
Evangelos Terpos, Noopur Raje, Peter Croucher, Ramon Garcia-Sanz, Xavier Leleu, Waltraud Pasteiner, Yang Wang, Anthony Glennane, Jude Canon, Charlotte Pawlyn
Journal: Blood Advances
Blood Adv (2021) 5 (3): 725–736.
https://doi.org/10.1182/bloodadvances.2020002378
Published: 2021
Includes: Supplemental data
Journal Articles

Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow

Free
Clinical Trials & Observations
Céline Mazzotti, Laure Buisson, Sabrina Maheo, Aurore Perrot, Marie-Lorraine Chretien, Xavier Leleu, Cyrille Hulin, Salomon Manier, Benjamin Hébraud, Murielle Roussel, Laura Do Souto, Michel Attal, Hervé Avet-Loiseau, Jill Corre
Journal: Blood Advances
Blood Adv (2018) 2 (21): 2811–2813.
https://doi.org/10.1182/bloodadvances.2018025197
Published: 2018
Includes: Supplemental data